Chardan Healthcare Acquisition Corp.
Status: Closed Deal
U=S+W
W=S/2@11.5
| IPO Proceeds, $M | $70.00M |
|---|---|
| IPO Date | Dec 14, 2018 |
| CEO | Jonas Grossman |
| Left Lead | Chardan |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | BioMx |
| Deal Announced | Jul 16, 2019 |
| Deal Size, $M | $253.75M |
| Deal Sector | Healthcare |
| Deal Geography | EEMEA |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Oct 23, 2019 |
| Amendment Vote | TBD |
| Closing Date | Oct 28, 2019 |
Formerly CHAC
PHGE
PHGE.W
| Price | $0.60 $0.06 |
|---|---|
| Last closing price | $0.60 |
| H/L, today | $0.58 / $0.63 |
| H/L, 52-week | $0.13 / $0.69 |
| Volume, today | 20,916 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.